These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15990707)

  • 1. Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases.
    Pozzi M; Redaelli E; Ratti L; Poli G; Guidi C; Milanese M; Calchera I; Mancia G
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):179-86. PubMed ID: 15990707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis.
    Pozzi M; Grassi G; Ratti L; Favini G; Dell'Oro R; Redaelli E; Calchera I; Boari G; Mancia G
    Am J Gastroenterol; 2005 May; 100(5):1110-6. PubMed ID: 15842586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome.
    Blei AT; Mazhar S; Davidson CJ; Flamm SL; Abecassis M; Gheorghiade M
    J Clin Gastroenterol; 2007; 41 Suppl 3():S323-9. PubMed ID: 17975484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial.
    Fontana RJ; Sanyal AJ; Mehta S; Doherty MC; Neuschwander-Tetri BA; Everson GT; Kahn JA; Malet PF; Sheikh MY; Chung RT; Ghany MG; Gretch DR;
    Am J Gastroenterol; 2006 May; 101(5):983-92. PubMed ID: 16573786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac alterations in cirrhosis: reversibility after liver transplantation.
    Torregrosa M; Aguadé S; Dos L; Segura R; Gónzalez A; Evangelista A; Castell J; Margarit C; Esteban R; Guardia J; Genescà J
    J Hepatol; 2005 Jan; 42(1):68-74. PubMed ID: 15629509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
    Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC;
    Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diastolic dysfunction in liver cirrhosis].
    Ratti L; Redaelli E; Guidi C; Rivera R; Wong F; Pozzi M
    Gastroenterol Hepatol; 2005 Dec; 28(10):649-55. PubMed ID: 16373018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
    Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
    Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of HCV infection in patients with advanced cirrhosis.
    Forns X; Navasa M; Rodés J
    Hepatology; 2004 Aug; 40(2):498. PubMed ID: 15368458
    [No Abstract]   [Full Text] [Related]  

  • 14. Impaired glucose tolerance: a possible contributor to left ventricular hypertrophy and diastolic dysfunction.
    Fujita M; Asanuma H; Kim J; Liao Y; Hirata A; Tsukamoto O; Minamino T; Hori M; Goto M; Node K; Kitakaze M
    Int J Cardiol; 2007 May; 118(1):76-80. PubMed ID: 16934350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.
    Sanyal AJ; Fontana RJ; Di Bisceglie AM; Everhart JE; Doherty MC; Everson GT; Donovan JA; Malet PF; Mehta S; Sheikh MY; Reid AE; Ghany MG; Gretch DR; Halt-C Trial Group
    Gastrointest Endosc; 2006 Dec; 64(6):855-64. PubMed ID: 17140886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
    Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of gallbladder motility in patients with chronic HCV hepatitis and with HCV cirrhosis.
    Buzaş C; Chira O; Mocan T; Acalovschi M
    Rom J Intern Med; 2011; 49(1):37-44. PubMed ID: 22026251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The assessment of heart function in children with chronic kidney disease (CKD)].
    Drozdz D; Kordon Z; Pietrzyk JA; Drozdz M; Rudziński A; Zachwieja K
    Pol Merkur Lekarski; 2008; 24 Suppl 4():98-100. PubMed ID: 18924516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.
    Wong F; Liu P; Lilly L; Bomzon A; Blendis L
    Clin Sci (Lond); 1999 Sep; 97(3):259-67. PubMed ID: 10464050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.